PROGRESS-AMS 1.0 Clinical Long Term Follow-Up
NCT01610102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2015-02-05
Summary
The primary objective of this study is to collect long term clinical follow-up data on all patients enrolled in the PROGRESS AMS-1.0 study to assess long term safety of the AMS-1.0
Conditions
- Long Term Safety of the AMS 1.0
Sponsors & Collaborators
-
Biotronik AG
lead INDUSTRY
Principal Investigators
-
Raimund Erbel, Prof. · Westdeutsches Herzzentrum Essen
-
Esther Gerteis · Biotronik AG
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- Australia
- Belgium
- Germany
- Netherlands
- Switzerland
Study Locations
More Related Trials
-
Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth
NCT00349895 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent
NCT01233453 ·Status: UNKNOWN ·Phase: PHASE4
-
Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction
NCT01489449 ·Status: COMPLETED ·Phase: PHASE4
-
Vascular Implant Safety and Efficacy Study
NCT03263858 ·Status: COMPLETED ·Phase: NA
-
Treatment of Coronary In-Stent Restenosis
NCT01735825 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis
NCT00598533 ·Status: COMPLETED ·Phase: PHASE4
-
A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China
NCT03736226 ·Status: ACTIVE_NOT_RECRUITING
-
Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
NCT02197559 ·Status: COMPLETED
-
PROMUS PREMIER™ China Post-Approval Study
NCT03273023 ·Status: COMPLETED
-
ALPHA LONG Study- BioMatrix AlphaTM Stent Study in Patients With CAD
NCT05799963 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
COMPARE-II- Vasomotion and Imaging Substudy
NCT01329237 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
NCT01405287 ·Status: COMPLETED ·Phase: PHASE2
-
Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction
NCT02890589 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
NCT01556126 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease
NCT04825886 ·Status: COMPLETED
-
Everolimus- Versus Biolimus-Eluting Stents in All-Comers
NCT01472705 ·Status: COMPLETED
-
Coronary Flow Reserve in Patients With Bio-active Stent or Everolimus-eluting Stent Implanted in Acute Coronary Syndrome
NCT01080872 ·Status: COMPLETED
-
Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome
NCT02049229 ·Status: UNKNOWN ·Phase: PHASE4
-
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
NCT01703000 ·Status: COMPLETED ·Phase: NA
-
Post-Approval Study of PROMUS Element™ in China
NCT01677585 ·Status: COMPLETED
-
An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease
NCT04110327 ·Status: ACTIVE_NOT_RECRUITING
-
PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study
NCT01148329 ·Status: COMPLETED
-
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
NCT00485030 ·Status: COMPLETED ·Phase: PHASE4
-
AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study
NCT01012869 ·Status: COMPLETED ·Phase: PHASE4
-
STENTYS Self-expanding Versus Balloon-expandable Stent in Acute Myocardial Infarction (AMI)
NCT01008085 ·Status: COMPLETED ·Phase: PHASE3